Previous results showed that in an inbred line (SSIN) derived from outbred SENCAR mice there is a dissociation between susceptibility to papilloma development and the malignant conversion of these into squamous cell carcinomas (SCC). To extend this conclusion, we designed an interstrain breeding experiment using the two-step carcinogenesis protocol in order to study the susceptibility to tumor progression of F1 offspring. The strains used were SSIN, BALB/c, both known for their resistance to papilloma progression, and SENCAR. Both the SSIN X SENCAR and SENCAR X SSIN F1s showed a promotion sensitivity similar to that of the SSIN mice. This behavior was also seen in the SSIN X (SSIN X SENCAR) and SSIN X (SENCAR X SSIN) backcrossed animals, suggesting that susceptibility to 12-O-tetradecanoylphorbol-13-acetate promotion under these protocol conditions is inherited as a dominant trait. The BALB/c X SENCAR F1s showed an average response that was intermediate between the two parental strains/stocks. Regarding the progression, all F1s showed a cumulative number of SCCs similar to the SENCAR progenitor. We also investigated the previously described switch of keratin 1 to 13 as a marker of premalignant progression, which is significatively delayed in SSIN mice compared with SENCAR mice. The SSIN X SENCAR F1s expressed this switch in a way similar to the SENCAR mice. These findings suggest that susceptibility to tumor progression is inherited as a dominant autosomal trait. The putative gene(s) that confers susceptibility is present in the SENCAR stock and was probably lost in the selection and inbreeding of the SSIN mice.
No takes yet. Share an insight, caveat, or question.
Stern et al. (1995) studied this question.